The progression of chronic obstructive pulmonary disease (COPD) is associated with marked alterations in circulating immune cell populations, but no studies have characterized alterations in these cell types across the full spectrum of lung function impairment in current and former smokers. In 6,299 subjects from the COPDGene and ECLIPSE studies, we related Coulter blood counts and proportions to cross-sectional FEV 1 adjusting for current smoking status. We also related cell count measures to three-year change in FEV 1 in ECLIPSE subjects. In a subset of subjects with blood gene expression data, we used cell type deconvolution methods to infer the proportions of immune cell subpopulations, and we related these to COPD clinical status. We observed that FEV 1 levels are positively correlated with lymphocytes and negatively correlated with myeloid populations such as neutrophils and monocytes. In multivariate models, absolute cell counts and proportions were associated with cross-sectional FEV 1 , and lymphocytes, monocytes, and eosinophil counts were predictive of three year change in lung function. Using cell type deconvolution to study immune cell subpopulations, we observed that subjects with COPD had a lower proportion of CD4+ resting memory cells and naive B cells compared to non-COPD smokers. Alterations in circulating immune cells in COPD support a mixed pattern of lymphocyte suppression and an enhanced myeloid cell immune response.
multiple cell types, current smoking status, and lung function. To explore the second hypothesis, we used two 25 cell type deconvolution methods to infer immune cell subpopulation proportions in a subset of smokers with 26 blood gene expression data in the ECLIPSE Study, and we validated these inferred cell type proportions against 27 measured CBC data. We then compared levels of inferred circulating immune cell subpopulations by COPD 28 status, confirming that inferred estimates of circulating immune cell types such as monocytes, naive B cells, and 29 resting T memory cells are altered in the COPD state. 30 31 Methods 
32

Study Populations
Recruitment criteria and study protocols for the ECLIPSE and COPDGene studies have been previously 33 reported. COPDGene enrolled 10,192 subjects across the entire GOLD spectrum between the ages of 45 and 80 34 with at least a 10 pack-year smoking history (22) . These subjects completed their Phase 1 study visit between 
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The Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study was a 39 multicenter study that enrolled subjects aged 40-75 with COPD and at least a 10-year smoking history (COPD 40 defined by FEV 1 < 80% of predicted and FEV 1 /FVC <= 0.7) or who were smokers without COPD (FEV 1 >85% and 41 FEV 1 /FVC > 0.7). Details of this study have been previously published (23) . Gene expression analyses were 42 performed in a subset of subjects in this study from whom genome-wide gene expression data were generated 43 on the Affymetrix Human U133 Plus2 chip as previously reported (24) . For both COPDGene and ECLIPSE, the 44 institutional review boards of all participating centers approved these studies, and written informed consent 45 was obtained from all subjects.
Phenotype and Covariate Definitions
48
In COPDGene and ECLIPSE, spirometry was performed before and after administration of 180 mcg of lung function). To determine the association between CBC measurements and change in FEV 1 , we used using the Wilcoxon-Mann-Whitney test. Significant cell type associations were considered to be those with a severity (Tables 2 and E2 ). Boxplots showing the amount of each cell type by GOLD stage for COPDGene and increasing COPD severity, the proportion of neutrophils increases and lymphocytes decreases. However, in 122 terms of absolute cell counts the number of neutrophils increases while the total number of lymphocytes 
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We evaluated these relationships in a series of models in COPDGene relating cell count, cell proportion,
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and current smoking (CS) to FEV 1 % of predicted while adjusting for inhaled and oral steroid use ( Table 3 ). The 128 models explaining the largest proportion of variance in FEV 1 , after adjusting for model complexity, included 129 both cell counts and proportions demonstrating that both measures have independent association to FEV 1 . significantly associated with lung function decline. Larger neutrophil proportions were associated with more lung function decline, with the opposite relationship observed for lymphocyte proportion.
143 Table 5 demonstrates that for multivariate models including counts and proportions of these four cell 144 types, cell counts, but not proportions, showed significant associations to change in FEV 1 . Absolute counts of 145 monocytes, eosinophils, and lymphocytes were significantly associated with FEV1 decline (p=0.0003, 0.0004, 146 and p=0.02, respectively). Higher levels of monocytes were associated with larger amounts of FEV 1 decline, and 147 the opposite pattern was present for lymphocytes and eosinophils.
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Association of Inferred Lymphocyte Subpopulations to COPD and COPD Subtypes
150
In a subset of 221 subjects from ECLIPSE with complete genome-wide blood gene expression and 151 covariate data (subject characteristics shown in Table E3 ), we used cell type deconvolution to estimate the 152 proportion of immune cell subpopulations in each study subject, and we related these proportions to COPD 153 case-control status.
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To first assess the performance of cell type deconvolution in blood gene expression from smokers, we 155 examined results from applying two methods that have been previously validated for the detection of immune 156 cell types, CIBERSORT and the linear regression (LR) method of Abbas (20, 21) . To benchmark these algorithms
We compared the inferred cell type proportions by COPD case/control status and observed that,
Inferred Cell Type Proportions Predict COPD Blood Gene Expression Subtypes
168
In a previous publication, the ECLIPSE blood gene expression data had been used to define COPD 169 molecular subtypes that differed in clinical characteristics and blood gene expression patterns, and we 170 previously demonstrated that these subtypes could not be recovered using CBC data alone (24) . To determine 171 whether these molecular subgroups could be accurately predicted from inferred cell count proportions, we 172 trained support vector machine classifiers to predict NBS subtype and COPD case/control status using CBC data, 173 clinical covariates, or inferred cell type proportions. Figure 3 demonstrates that predictive models for NBS 174 subtypes using inferred cell type proportions classified subjects by COPD molecular subtype with high accuracy
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(AUC = 0.95) and demonstrated better performance than models using only CBC cell-type quantities (AUC = 176 0.53) or clinical covariates (AUC = 0.65). Predictive models for COPD case/control status using inferred cell type 177 proportions also showed statistically significant, but less powerful, predictive performance (AUC = 0.71), with 178 the cell type subpopulation models still outperforming the models using CBC data (Table E4 ).
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We compared levels of the inferred cell type proportions between the NBS-MI and NBS-LI COPD 180 molecular subtypes and observed that the list of specific immune cell types that were significantly different 181 between COPD molecular subtypes was more extensive than between COPD cases and controls. This list
included T-regulatory cells, CD4 resting and activated memory T-cells, memory B-cells, aggregated T-cells,
Using two large cohorts enriched for subjects with COPD, we characterized alterations in circulating in the absolute count of neutrophils, 2) monocytes and eosinophils have strong multivariate associations to 
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To study immune cell subpopulations not quantified by CBC, we explored the use of cell type 204 deconvolution approaches to quantify 22 distinct cell subpopulations in a subset of ECLIPSE subjects with blood 205 genome-wide gene expression data. Both methods we employed have been previously validated against flow 206 cytometry quantifications (20, 21) , and these methods are a promising alternative for estimating cell type 207 proportions in large study samples with available expression data. However, these approaches have not been 208 widely applied in smokers with COPD. Our findings demonstrate that in smokers enriched for COPD, the 209 deconvolution approaches studied yielded consistent and reasonably reliable estimates of neutrophil and lymphocyte cell proportions with mixed performance for other cell types. Inferred cell type proportions
This study also has important limitations. We did not have access to immune cells in the lung or specific compartment. We also were not able to characterize immune cell functional states through cytokine profiling 237 or quantification of response to antigenic stimulation. While we observed significant associations between 238 circulating immune cell subpopulations and COPD, further study is required to determine the 239 pathophysiological significance of these observations. We did not have flow cytometry values against which we 240 could benchmark our cell type deconvolution estimates, but we did have Coulter counter data available, and 241 our deconvolution results were generated using methods that has been previously validated against flow 242 cytometry for immune cell populations (20, 21) .
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In conclusion, analysis of CBC counts and proportions in >6,000 subjects from the COPDGene and 244 ECLIPSE studies demonstrated that cross-sectional FEV 1 is associated with alterations in multiple circulating 245 immune cell types, including total neutrophil count. COPD disease progression, as quantified by decline in FEV 1 , 246 is associated with increased absolute monocyte counts and decreased lymphocytes and eosinophil counts at 247 baseline. Cell type deconvolution is a viable approach to simultaneously study multiple immune cell populations 248 in smokers with COPD, and our findings support a model of suppressed adaptive immune responses coupled 249 with enhanced innate immunity. Future studies to characterize COPD-related alterations in more fine-grained 250 immune cell types will benefit from quantification of both cell type proportions and absolute counts. Cell Proportions ---0.39 (0.10) * ---0.75 (0.11) * --- Models analyze one cell type at a time. All models are adjusted for FEV1 % of predicted at baseline, number of days of follow-up, inhaled corticosteroid use at baseline, and smoking status at baseline and at last study visit. Values are mean (SD) unless otherwise indicated. P-values calculated using Wilcoxon rank sum test. The following cell types were not analyzed because they were detected in less than 10% of samples: M1 Macrophages, activated dendritic cells, activated Mast cells, gamma-delta T-cells, and T follicular helper cells. 
